Trial0

Clinical trial · NCT03894254 · RECRUITING · NA

Predictive Factors of Autonomy Loss in Real-life Cohort

Sponsor: Hospices Civils de Lyon

We save this real registry record and notify you if its published status changes. Create an account to add profile details that improve future matching.

Summary

The Alzheimer's disease or related disorders (ADRD) are among the most disabling diseases because of their main features such as cognitive impairment, loss of functional autonomy and behavioural disorders. In absence of current curative treatment, the identification of the predictive risk factors of progression of the disease, evaluated through its main symptoms, represents a major stake of public health. The Investigators aim at developing a regional database, which includes the patient medical records on a prospective basis, in collaboration with the medical and administrative staff and with the University hospital computer science departments. The main objective is to study the predictive factors associated with change in functional autonomy level, measured every 6 to 12 months in centres across Region Auvergne Rhone-Alpes in France. The real-life study population will consist in about 5400 patients with ADRD. The inclusion period will be of 3 years, the length of follow-up of each patient will be of 10 years max for a total study length of 13 years.

Interventions

  • no intervention · OTHER

    This is study carried out in current practice. Patients are undergoing a medical examination in a memory center, with extensive and systematic evaluations for the study involving the following tests: IADL, DAD6, New AGGIR, NPI, and mini-Zarit) assessing the functions (autonomy, behavior and caregiver burden).

Published eligibility criteria

Verbatim from the registry. Only the site can decide how these apply to a specific patient.

Inclusion Criteria:

* Patients aged 18 years and older, undergoing a medical visit in a memory center or neuro-cognition service
* Patients living at home or in housing
* Patients with memory impairment, at all stage of the disease

Exclusion Criteria:

* Patients in institution
* Patients under legal protection
* Patients with a hearing or visual impairment, which prevents carrying out examinations

Sites (5)

  • Hôpital Dugoujon, Caluire-et-Cuire, France · RECRUITING
  • Centre Hospitalier Lyon Sud, Lyon, France · RECRUITING
  • Service de neuro-cognition et neuro-ophtalmologie du Groupement Hospitalier Est, Lyon, France · RECRUITING
  • CHU Saint-Etienne, Saint-Etienne, France · RECRUITING
  • Centre Mémoire de Ressources et de Recherche de Lyon, Villeurbanne, France · RECRUITING

Not medical advice. Trial0 is a navigation service, not a medical provider. Nothing here is medical advice or a recommendation to pursue any treatment; eligibility matching is informational, based on published registry criteria, and only the trial site or treating clinician can determine actual eligibility. Decisions belong with the patient and their own doctors. Registry data refreshed at most hourly; last update posted 2022-05-02.